(Biogerontology Research Foundation) The Biogerontology Research Foundation announces the international collaboration on signaling pathway perturbation-based transcriptomic biomarkers of aging. On Nov. 16, scientists at the Biogerontology Research Foundation alongside collaborators from Insilico Medicine Inc., Johns Hopkins University, Albert Einstein College of Medicine, Boston University, Novartis, Nestle and BioTime Inc. announced the publication of their proof of concept experiment demonstrating the utility of a novel approach for analyzing transcriptomic, metabolomic and signalomic data sets, titled iPANDA, in Nature Communications.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2fg2mGy
No comments:
Post a Comment